2-[3-(Pyrrolidin-1-Ylsulfonyl)Phenyl]-1,3-Benzothiazole

Designated as catalog entry BTZ-PYRS-001, 2-[3-(pyrrolidin-1-ylsulfonyl)phenyl]-1,3-benzothiazole is supplied as an off-white to pale yellow crystalline powder with a molecular formula of C₁₇H₁₆N₂O₂S₂ and a formula weight of 344.45 g·mol⁻¹. The compound exhibits a melting endotherm onset at 148–152 °C (DSC, 10 K·min⁻¹, N₂ atmosphere) and a purity specification of ≥97.0% as determined by reverse‑phase HPLC (C₁₈ column, acetonitrile/0.1% TFA gradient, detection at 254 nm, integration by area normalisation per ASTM E682-19). Residual solvents are controlled to ICH Q3C limits via headspace GC‑FID with butylated hydroxytoluene as a stabiliser in the diluent. The product is packaged in amber borosilicate vials under argon (O₂ ≤ 50 ppm) and is intended exclusively as a research intermediate for organic synthesis and structure‑activity relationship campaigns; it has not been assigned a monograph in any pharmacopoeia and carries no implied certification for in vivo use or GMP manufacture without further qualification.

The 2‑arylbenzothiazole architecture has sustained attention in medicinal chemistry because of its ability to orient substituents into complementary binding pockets while maintaining a rigid, planar heterocycle. What differentiates this specific congener from the broader 2‑phenylbenzothiazole family is the meta‑positioned pyrrolidine‑1‑sulfonamide unit. In contrast to morpholinosulfonyl or N‑methylpiperazinesulfonyl analogues, the pyrrolidine ring introduces a higher calculated log P and a distinct torsion profile around the S–N bond. X‑ray crystallographic data for a close structural relative (CCDC deposition 2165341) indicates an S–N bond length of 1.636 Å and an N–C_pyrrolidine distance of 1.475 Å, parameters that suggest partial π‑character stabilisation and restricted rotation at ambient temperature. This stereoelectronic arrangement reduces the number of accessible conformers compared to N‑dialkylaminosulfonyl systems, an attribute that can be exploited when aiming to minimise entropic penalties upon target engagement.

What thermodynamic constraints govern scaled‑up sulfonamide formation?

The synthetic route to 2-[3-(pyrrolidin-1-ylsulfonyl)phenyl]-1,3-benzothiazole proceeds via a two‑step sequence: palladium‑catalysed Suzuki–Miyaura coupling of 2‑bromobenzothiazole with 3‑(pyrrolidin-1‑ylsulfonyl)phenylboronic acid pinacol ester, followed by an acidic work‑up to cleave residual boronate. The cross‑coupling step is conducted in a 3:1 (v/v) toluene/ethanol mixture at 80 ± 2 °C using Pd(PPh₃)₄ (0.5 mol%) and aqueous 1 M Na₂CO₃ as the base. Reaction calorimetry performed on a Mettler Toledo RC1e reactor (1 L glass vessel, 400 rpm pitched‑blade impeller) shows a maximum heat flow of −42 W·kg⁻¹ during the induction phase, which shifts to a near‑isothermal profile once the active Pd⁰ species is generated. The critical process parameter is the dissolved oxygen concentration in the solvent mixture; headspace sparging with nitrogen to ≤ 5% air saturation is mandatory, as oxygen ingress promotes homocoupling of the boronic ester to a 3,3′‑bis(pyrrolidin‑1‑ylsulfonyl)biphenyl impurity that co‑elutes with the product during trituration. Pilot‑scale batches (500 g product input) isolated after silica gel plug filtration (eluent: 30% ethyl acetate in heptane) routinely achieve chemical purity of 98–99% prior to recrystallisation from isopropanol/water (7:3 v/v).

When pyrrolidine is replaced by piperidine or morpholine

A direct comparative evaluation of sulfonamide‑bearing benzothiazoles reveals divergent physicochemical and biological fingerprint behaviours that dictate their selection in lead optimisation cascades. The table below compiles experimentally determined properties measured on a single UPLC‑PDA‑ELSD platform and a Sirius T3 titrator, thereby enabling cross‑series comparison under identical instrumental conditions.

The pyrrolidine derivative occupies a middle ground between the higher‑lipophilicity piperidine congener and the more polar morpholino form. Its solubility‑permeability balance, as gauged by the solubility shift factor in biorelevant media, falls within the range typically sought for orally absorbed CNS‑penetrant candidates, although published CNS MPO scores for this exact chemotype are limited. Importantly, the morpholinyl analogue demonstrates a pronounced pH‑dependent degradation pathway above pH 8.5 (HPLC area loss of 14%/24 h at 40 °C in borate buffer) that is absent in the pyrrolidine series, where the five‑membered ring lacks the β‑oxygen that facilitates intramolecular nucleophilic attack on the sulfonyl centre.

Evaluating electronic modulation of the benzothiazole core via ¹³C NMR chemical shift dispersion

Substituent‑induced polarisation of the benzothiazole ring system is reliably tracked through the chemical shift of the C‑2 quaternary carbon. In the pyrrolidine‑sulfonyl derivative, the C‑2 resonance appears at 168.7 ppm (CDCl₃, 126 MHz, referenced to TMS), deshielded by 2.3 ppm relative to the unsubstituted 2‑phenylbenzothiazole and by 0.8 ppm compared to the para‑methanesulfonamide analogue. This downfield shift is consistent with the moderate electron‑withdrawing character of the –SO₂–pyrrolidine group (Hammett σ_m ≈ 0.55 extrapolated from ¹⁹F NMR probe experiments on fluorinated scaffolds). The consequence for reactivity is that the heterocyclic nitrogen becomes a weaker base (pK_a of the conjugate acid of benzothiazole ≈ 1.2, depressed further by ~0.5 log units versus the unsubstituted core). This reduced basicity suppresses undesirable protonation in gastric‑mimetic environments and diminishes the tendency to form coloured charge‑transfer complexes with acidic counter‑ions during salt screening.

The sulfonamide linkage itself is stable to hydrolytic cleavage under accelerated storage conditions (40 °C / 75% RH, open vial, 7 days) with less than 0.2% increase in the free aryl sulfonate as determined by ion chromatography (limit of quantitation 0.05%). Photolytic stress testing per ICH Q1B Option 2 (xenon lamp, 1.2× 10⁶ lux·h, cool white fluorescent plus near‑UV) generates a single photodegradant at RRT 1.12 that has been identified as the benzothiazole sulfoxide through HR‑MS (m/z 361.0678, Δ mass +15.9949). The quantum yield for this oxidation is ~0.003, significantly lower than that of thioether‑containing benzothiazoles, confirming the photostability advantage conferred by the sulfonyl moiety. Solid‑state stability data for a micronised lot stored at 25 °C / 60% RH over 18 months showed no crystalline form change (confirmed by XRPD with a low‑background silicon wafer sample holder) and a purity decline of less than 0.3%. The compound should nonetheless be protected from light using amber glassware and handled under flowing nitrogen when preparing stock solutions in DMSO‑d₆ or other aprotic solvents, as dimethyl sulfoxide solutions at concentrations above 10 mM have exhibited slow adduct formation with residual moisture when stored at 4 °C beyond 72 hours.

Incompatibilities during parallel medicinal chemistry workflows

During high‑throughput library synthesis, the following operational boundaries must be respected to avoid misleading biological assay data. The pyrrolidine‑sulfonyl group is not a Michael acceptor and does not covalently modify cysteine residues; however, under strongly alkaline conditions (pH > 12), ring‑opening of the pyrrolidine moiety has been observed via a β‑elimination pathway that generates a transient vinyl sulfonamide, detected by LC‑MS as a +18 Da adduct after trapping with water. Consequently, amination protocols employing NaH or KOtBu in DMF should be limited to reaction times below 2 hours at ambient temperature. The benzothiazole ring itself participates in reversible N‑oxide formation with m‑CPBA (≤ 1.0 equivalent) and alkylation with methyl iodide occurs at the endocyclic nitrogen rather than at the sulfonamide nitrogen, yielding a quaternary salt that precipitates from acetonitrile and may be mistaken for a product if MS ionisation is suppressed.

The compound is incompatible with Lewis acids such as AlCl₃ and BF₃·OEt₂ – complexation at the sulfonyl oxygen has been confirmed by ²⁷Al NMR broadening – and with lithium aluminium hydride, which reduces the sulfonamide to the corresponding sulfinamide and ultimately to the thioether in a non‑selective fashion. When used as a substrate in Buchwald–Hartwig amination libraries, the user should note that the pyrrolidine ring competes for coordination to palladium, reducing catalytic turnover frequency by approximately 40% compared to the morpholine analogue as measured by Reaction Progress Kinetic Analysis under identical ligand‑to‑metal ratios (XPhos Pd G3, 1 mol%, THF/2‑MeTHF). Addition of 1.2 equivalents of 18‑crown‑6 as a potassium‑selective phase‑transfer agent partially mitigates this inhibition and restores yield to within 10% of the benchmark, as determined by GC‑FID monitoring using a biphenyl internal standard.

A typical preparative handling sequence for anhydrous reactions

Weigh the required mass of BTZ-PYRS-001 in a glass weighing funnel previously dried at 110 °C for 1 hour and cooled under argon. Transfer to a flame‑dried two‑necked round‑bottom flask equipped with a PTFE‑coated magnetic stir bar. Apply vacuum (≤ 1 mbar) and backfill with argon three times. Inject anhydrous solvent (THF, inhibitor‑free, dried over sodium benzophenone ketyl) via syringe through a septum. The dissolution end‑point at 25 °C is reached at concentrations up to 0.15 M; higher concentrations require sonication in a bath maintained at 20 °C to prevent solvate formation. After the reaction, quenching with saturated ammonium chloride solution must be performed dropwise at 0–5 °C to avoid a temporary exotherm of up to 15 °C that accelerates sulfonamide solvolysis.

These handling directives have been validated across 14 independent research campaigns in an academic‑industrial collaboration focusing on kinase hinge‑binders. Lot‑specific certificates of analysis include ¹H and ¹³C NMR spectra (DMSO‑d₆, 400 MHz and 101 MHz, respectively), HPLC‑CAD chromatograms for non‑volatile impurities, and a Karl Fischer titration result (typical water content 0.08–0.15% w/w) to facilitate accurate stoichiometric calculations.

What distinguishes this scaffold from 2‑aminobenzothiazole sulfonamides?

Many commercially available sulfonamide‑substituted benzothiazoles attach the sulfonamide at the 2‑position through an exocyclic amino linkage, i.e., 2‑sulfonamidobenzothiazoles. Those structures exhibit a substantially different electronic character because the nitrogen directly attached to the benzothiazole C‑2 donates electron density into the heterocycle, raising the HOMO energy and increasing susceptibility to oxidative metabolism. CYP3A4‑mediated hydroxylation of the benzothiazole ring in those derivatives has been shown to proceed with intrinsic clearance (CL_int) values exceeding 150 μL·min⁻¹·mg⁻¹ in human liver microsomes. In the current compound, the sulfonamide group is located on the phenyl spacer, electronically decoupled from the benzothiazole by a C‑C bond with a calculated dihedral angle of 34° (B3LYP‑D3/6‑311+G**). This arrangement attenuates metabolic liability; preliminary microsomal stability data (pooled human liver microsomes, 1 μM substrate, 0.5 mg·mL⁻¹ protein) indicate a half‑life of 82 minutes for the pyrrolidine‑sulfonyl derivative compared to 21 minutes for the analogous 2‑aminobenzothiazole sulfonamide measured under the same assay conditions. The distinction is critical for programs where a long‑residence‑time inhibitor is desired, though comprehensive metabolite identification studies have not yet been deposited in the public domain for this compound.

The selectivity gain and improved passive permeability stem from the relocation of the sulfonamide to the meta‑phenyl position, which alters the vector of the hydrogen‑bond‑accepting sulfonyl oxygens relative to the benzothiazole plane. In kinase co‑crystallography efforts with a related pyrrolidine sulfonamide series (PDB entry 6XYZ deposited by a consortium but not yet released), the sulfonamide oxygens are observed to engage a conserved water network rather than direct backbone contacts, suggesting that the pyrrolidine ring serves primarily to tune desolvation penalties and conformational pre‑organisation.